undefined undefined
NaN.000
NaN.00%
Major earnings expected before the bell on Thursday include: Medical Properties Trust (MPW) Plug Power (PLUG) Roblox (RBLX) Viatris (VTRS) Warner Bros. Discovery (WBD) Other earnings slated for releas...
今天 00:34
Amylyx's AMX0035 data in treating Wolfram syndrome, with interim data indicating positive effects on diabetes progression, visual decline, and overall disease burden. Safety profile consistent.
04-11 01:14
In the last three months, 6 analysts have published ratings on Amylyx Pharma (N...
04-08 20:00
HC Wainwright & Co. analyst Andrew Fein maintains Amylyx Pharma (NASDAQ:AMLX) with a Buy and maintains $8 price target.
04-08 19:11
Amylyx Pharmaceuticals (NASDAQ:AMLX) on Thursday formally announced its decision to withdraw Relyvrio, an FDA-approved therapy for the neurodegenerative disease, amyotrophic lateral sclerosis (ALS), f...
04-04 19:32
Relyvrio/Albrioza will no longer be available for new patients as of today; Patients currently on therapy in the U.S. and Canada who, in consultation with their physician, wish to continue can be transitioned to a
04-04 19:16
LOS ANGELES, April 1, 2024 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsui...
04-02 04:30
Goldman Sachs analyst Corinne Johnson has maintained their neutral stance on AM...
03-28 04:15